Condition
Adverse Effect of Glucocorticoids and Synthetic Analogues
Total Trials
3
Recruiting
0
Active
0
Completed
1
Success Rate
50.0%-37% vs avg
Key Insights
Highlights
Success Rate
50% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 80/100
Termination Rate
33.3%
1 terminated out of 3 trials
Success Rate
50.0%
-36.5% vs benchmark
Late-Stage Pipeline
33%
1 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
50% success
Data Visualizations
Phase Distribution
2Total
Not Applicable (1)
P 4 (1)
Trial Status
Unknown1
Completed1
Terminated1
Trial Success Rate
50.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (3)
Showing 3 of 3 trials
NCT02386735Not ApplicableTerminated
Reduction of Corticosteroid Use in Outpatient Treatment of Exacerbated COPD
NCT02365077Unknown
GWAS Identified Susceptibility Loci for Glucocorticoid-induced FHN in the Chinese Population
NCT01378689Phase 4CompletedPrimary
Improving Bone Health Among Rheumatoid Arthritis (RA) Patients on Chronic Glucocorticoids
Showing all 3 trials